Trial Details
RECRUITINGBasic Information
| Clinical ID | c158 |
|---|---|
| Identifier | NCT07073079 |
| Trial Title | A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | - |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Bari |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2025-07-14 |
|---|---|
| Primary Completion Date | 2027-12 |
| Completion Date | 2027-12 |